{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:02:22Z","timestamp":1779894142086,"version":"3.53.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00761"],"award-info":[{"award-number":["PI20\/00761"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hereditary angioedema (HAE) is a rare genetic disease, characterized by transient and self-limiting episodes of subcutaneous or submucosal swelling that spontaneously resolve within two to five days. The most common form of HAE, HAE-C1-INH, is caused by deleterious mutations in the <jats:italic>SERPING1<\/jats:italic> gene, encoding the C1-Inhibitor protein, and its diagnosis is confirmed by decreased C1-INH function. Distinctively from other genetic forms of HAE, up to 15-20% of HAE-C1-INH cases are sporadic caused by <jats:italic>de novo<\/jats:italic> mutations. Here, we report a patient with apparently sporadic HAE-C1-INH. The patient had compatible clinical symptoms and a markedly low C1-INH function, and the parents showed normal values of C4 and normal C1-INH function. In the patient, we identified a novel splice site mutation in <jats:italic>SERPING1<\/jats:italic> (c.890-1G&amp;gt;C) and, by cDNA analysis, we confirmed its pathogenicity. Despite normal C1-INH function in the parents, we found that the mother was, unexpectedly, a mutation carrier. The inverted profile of the Sanger peaks compared with the patient, strongly suggested the presence of gonosomal mosaicism in the mother. We confirmed and quantified the mosaicism in different tissues by high depth NGS-based deep amplicon sequencing, showing a similar frequency of the variant ranging from 17 to 23%. In this study, we present the first case of gonosomal mosaicism in a family with a single child affected with HAE-C1-INH from unaffected parents. Our results underscore the importance of parental genetic testing in all patients, regardless of whether the parents are affected, and highlights the implications of gonosomal mosaicism for genetic counseling.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1550380","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:09:22Z","timestamp":1738825762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["De Novo or inherited: gonosomal mosaicism in hereditary angioedema due to C1 inhibitor deficiency"],"prefix":"10.3389","volume":"16","author":[{"given":"Laura","family":"Batlle-Mas\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janire","family":"Perurena-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vi\u00f1as-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Aguil\u00f3-Cucurull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Fern\u00e1ndez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"Gil-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Guilarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13023-024-03265-z","article-title":"Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review","volume":"19","author":"Guan","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13223-021-00537-2","article-title":"Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report","volume":"17","author":"Bork","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jaci.2024.03.024","article-title":"Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus","volume":"154","author":"Reshef","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2022.835503","article-title":"SERPING1 variants and C1-INH biological function: A close relationship with C1-INH-HAE","volume":"3","author":"Drouet","year":"2022","journal-title":"Front Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198707023170101","article-title":"Altered C1 inhibitor genes in type I hereditary angioedema","volume":"317","author":"Stoppa-Lyonnet","year":"1987","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/all.2018.73.issue-2","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/all.v74.12","article-title":"Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin","volume":"74","author":"Bork","year":"2019","journal-title":"Allergy."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/all.v75.11","article-title":"A myoferlin gain-of-function variant associates with a new type of hereditary angioedema","volume":"75","author":"Ariano","year":"2020","journal-title":"Allergy."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.01.011","article-title":"Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation","volume":"148","author":"Bork","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jaci.2024.05.017","article-title":"DAB2IP associates with hereditary angioedema: Insights into the role of VEGF signaling in HAE pathophysiology","volume":"154","author":"D\u2019Apolito","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.jacig.2024.100223","article-title":"Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency","volume":"3","author":"Vincent","year":"2024","journal-title":"J Allergy Clin Immunol Glob mayo"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.03.008","article-title":"The expanding spectrum of mutations in hereditary angioedema","volume":"9","author":"Veronez","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy."},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/humu.23917","article-title":"SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes","volume":"41","author":"Ponard","year":"2020","journal-title":"Hum Mutat"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2023.04.023","article-title":"Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variants","volume":"152","author":"Ry\u00f8","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1172\/JCI98869","article-title":"Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema","volume":"129","author":"Haslund","year":"2019","journal-title":"J Clin Invest."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8543-x","article-title":"Genetics of hereditary angioedema revisited","volume":"51","author":"Germenis","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00753-2","article-title":"Deep intronic mutation in SERPING1 caused hereditary angioedema through pseudoexon activation","volume":"40","author":"Hujov\u00e1","year":"2020","journal-title":"J Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.12.009","article-title":"A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency","volume":"69","author":"Vatsiou","year":"2020","journal-title":"Allergol Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2018.05.029","article-title":"Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency","volume":"667","author":"Loules","year":"2018","journal-title":"Gene. 15 agosto"},{"key":"B23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-genet-071719-020519","article-title":"Variation and evolution of human centromeres: A field guide and perspective","volume":"55","author":"Miga","year":"2021","journal-title":"Annu Rev Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.4.1551","article-title":"Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements","volume":"87","author":"Stoppa-Lyonnet","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.145","article-title":"Mosaicism in health and disease - clones picking up speed","volume":"18","author":"Forsberg","year":"2017","journal-title":"Nat Rev Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jaip.2020.02.038","article-title":"Validation of the angioedema control test (AECT)-A patient-reported outcome instrument for assessing angioedema control","volume":"8","author":"Weller","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0479","article-title":"HAE-AS: A specific disease activity scale for hereditary angioedema with C1-inhibitor deficiency","volume":"31","author":"Forjaz","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/all.2012.67.issue-10","article-title":"Development and construct validation of the angioedema quality of life questionnaire","volume":"67","author":"Weller","year":"2012","journal-title":"Allergy."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.253","article-title":"A novel RNA splice site mutation in the C1 inhibitor gene of a patient with type I hereditary angioedema","volume":"43","author":"Sekijima","year":"2004","journal-title":"Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.10.004","article-title":"International consensus on the use of genetics in the management of hereditary angioedema","volume":"8","author":"Germenis","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41576-024-00715-z","article-title":"Human embryonic genetic mosaicism and its effects on development and disease","volume":"25","author":"Waldvogel","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00046","article-title":"Uncovering low-level maternal gonosomal mosaicism in X-linked agammaglobulinemia: implications for genetic counseling","volume":"11","author":"Rivi\u00e8re","year":"2020","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2006.00643.x","article-title":"Gonadal mosaicism in hereditary angioedema","volume":"70","author":"Guarino","year":"2006","journal-title":"Clin Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaip.2017.07.002","article-title":"Hereditary angioedema in 2 sisters due to paternal gonadal mosaicism","volume":"6","author":"Ebo","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60557-1","article-title":"Paternal mosaicism and hereditary angioedema in a Taiwanese family","volume":"99","author":"Yu","year":"2007","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1550380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:09:27Z","timestamp":1738825767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1550380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2025.1550380"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1550380","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1550380"}}